Development of Carborane‐Based Halogenated Naphthyridinone‐Analogues as Cannabinoid Receptor Type 2 (CB 2 R) Ligands
ChemMedChem · 11.09.2025 · 20 (17)
DOI: 10.1002/cmdc.202500251 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 25.06.2025. Verfasst von Lea Ueberham und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Bioanalytical Chemistry, Centre for Biotechnology and Biomedicine (BBZ), Faculty of Chemistry and Mineralogy, Universität Leipzig, Deuts…. Hauptthemen laut MEDLINE: Receptor, Cannabinoid, CB2, Naphthyridines, Boranes, Drug Development. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Romanian Ministry of Research, Innovation and Digitalization.
Abstract (Originalsprache)
The cannabinoid receptor type 2 (CB 2 R) is overexpressed under pathological conditions. Positron emission tomography is a noninvasive imaging technique for diagnosing disease states, but requires radiotracers with high affinity and selectivity towards CB 2 R. Currently, there is no suitable candidate routinely used in the clinics. The naphthyridinone scaffold, a promising core structure, has been modified in the past years. The modification of naphthyridinone carboxamides with carboranes as hydrophobic surrogates for purely organic moieties can lead to beneficial CB 2 R ligands with high affinity, selectivity, and metabolic stability. Herein, synthesis and characterization of eight ortho ‐, meta ‐, para ‐, and nido ‐carborane‐based naphthyridinone ligands are reported, along with their in vitro binding affinity towards human CB 1 R and CB 2 R. Additionally, the results of in silico investigations are presented. The meta ‐ and para ‐carborane derivatives show high affinity in the low nanomolar range and good selectivity towards CB 2 R. Only a minor influence of bromo‐ versus iodo‐substitution of the compounds is observed experimentally, while in silico data suggest a stronger influence of the halogen atom, resulting in a different order of the respective carborane isomers regarding their CB 2 R affinity. Although these compounds do not outperform the known organic derivatives, these promising carborane‐based naphthyridinones extend the portfolio of potentially useful CB 2 R ligands.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Bioanalytical Chemistry, Centre for Biotechnology and Biomedicine (BBZ), Faculty of Chemistry and Mineralogy, Universität Leipzig, Deutscher Platz 5, 04103, Leipzig, Germany.
- Department of Experimental Neurooncological Radiopharmacy, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Research Site Leipzig, Permoserstraße 15, 04318, Leipzig, Germany.
- Institute for Drug Discovery, Faculty of Medicine, Universität Leipzig, Brüderstraße 34, 04103, Leipzig, Germany.
- Faculty of Chemistry and Chemical Engineering, Department of Chemistry, Babeș-Bolyai University, Str. Arany Janos Nr. 11, RO-400028, Cluj-Napoca, Romania.
ORCID-Profile: Lea Ueberham, Winnie Deuther-Conrad, Peter Lönnecke, Aleksandr Kazimir, Evamarie Hey-Hawkins
Förderung
- Deutsche Forschungsgemeinschaft
- Romanian Ministry of Research, Innovation and Digitalization
Zitieren
APA
Ueberham, L., Deuther-Conrad, W., Lönnecke, P., Kazimir, A., & Hey-Hawkins, E. (2025). Development of Carborane‐Based Halogenated Naphthyridinone‐Analogues as Cannabinoid Receptor Type 2 (CB 2 R) Ligands. ChemMedChem, 20(17). https://doi.org/10.1002/cmdc.202500251
Vancouver
Ueberham L, Deuther-Conrad W, Lönnecke P, Kazimir A, Hey-Hawkins E. Development of Carborane‐Based Halogenated Naphthyridinone‐Analogues as Cannabinoid Receptor Type 2 (CB 2 R) Ligands. ChemMedChem. 2025;20(17). doi:10.1002/cmdc.202500251
BibTeX
@article{Ueberham2025,
author = {Ueberham, Lea and Deuther-Conrad, Winnie and Lönnecke, Peter and Kazimir, Aleksandr and Hey-Hawkins, Evamarie},
title = {Development of Carborane‐Based Halogenated Naphthyridinone‐Analogues as Cannabinoid Receptor Type 2 (CB 2 R) Ligands},
journal = {ChemMedChem},
year = {2025},
volume = {20},
number = {17},
doi = {10.1002/cmdc.202500251}
}
EUVIMED